• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

JMA J . Intramuscular vs. Subcutaneous: Rethinking Influenza Vaccination Strategy in Japan

tetano

Editor, Senior Moderator
JMA J


. 2024 Jan 15;7(1):111-113.
doi: 10.31662/jmaj.2023-0122. Epub 2023 Dec 11. Intramuscular vs. Subcutaneous: Rethinking Influenza Vaccination Strategy in Japan

Yudai Kaneda[SUP] 1 [/SUP], Uiri Kaneda[SUP] 2 [/SUP], Akihiko Ozaki[SUP] 3 [/SUP], Tetsuya Tanimoto[SUP] 4 [/SUP]



Affiliations
Free PMC article Abstract

In Japan, inactivated vaccines, including the influenza vaccine, are administered subcutaneously, which is contrary to global recommendations for intramuscular injections. This practice is attributed to historical medical incidents and unchallenged conventions. However, this outdated method, which differs from that of international standards and is linked with less immunogenicity and more adverse reactions, may contribute to vaccination hesitancy. Therefore, with the adoption of intramuscular vaccination administration, which was widely adopted in the coronavirus disease 2019 vaccination, a shift in the Japanese health policy to conform to international standards potentially improves vaccine acceptance and effectiveness.

Keywords: COVID-19; Influenza; International Standards; Japan; Subcutaneous Vaccination.

 
Back
Top Bottom